Related references
Note: Only part of the references are listed.Challenges in the development of an HIV-1 vaccine
Dan H. Barouch
NATURE (2008)
Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
Sheng-Kai Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIVCD8+ T cell epitopes
Masahiko Kaizu et al.
IMMUNOGENETICS (2007)
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
John T. Loffredo et al.
JOURNAL OF VIROLOGY (2007)
Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120
Patrick W. -P. Hong et al.
JOURNAL OF VIROLOGY (2007)
Current concepts: An HIV vaccine - Evolving concepts
Margaret I. Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
AIDS virus envelope spike structure
Kenneth H. Roux et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2007)
Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication
Thomas C. Friedrich et al.
JOURNAL OF VIROLOGY (2007)
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ
Giulia Zanetti et al.
PLOS PATHOGENS (2006)
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2GI2 as probed by Fc-tagged gp120
James M. Binley et al.
RETROVIROLOGY (2006)
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication
Levi J. Yant et al.
JOURNAL OF VIROLOGY (2006)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
PL Moore et al.
JOURNAL OF VIROLOGY (2006)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
Dissection of the carbohydrate specificity of the broadly neutralizing-anti-HIV-1 antibody 2G12
DA Calarese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques
J Su et al.
INTERNATIONAL IMMUNOLOGY (2005)
Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12
KH Roux et al.
MOLECULAR IMMUNOLOGY (2004)
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
JA Binley et al.
JOURNAL OF VIROLOGY (2004)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12
S Wolbank et al.
JOURNAL OF VIROLOGY (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
RS Veazey et al.
NATURE MEDICINE (2003)
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication
BR Mothé et al.
JOURNAL OF VIROLOGY (2003)
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
P Poignard et al.
JOURNAL OF VIROLOGY (2003)
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection
ZQ Zhang et al.
JOURNAL OF VIROLOGY (2002)
Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1
J Lue et al.
JOURNAL OF VIROLOGY (2002)
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
CN Scanlan et al.
JOURNAL OF VIROLOGY (2002)
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency
R Pal et al.
JOURNAL OF VIROLOGY (2002)
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies
Y Nishimura et al.
JOURNAL OF VIROLOGY (2002)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIVSF162P3
JM Harouse et al.
JOURNAL OF VIROLOGY (2001)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
TW Baba et al.
NATURE MEDICINE (2000)